SEC Filings for ADC Therapeutics SA (ADCT)

$ 27.09   0.37 (+1.38%) Volume: 119.17k 4:00 PM EDT 27-Oct-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
SC 13D/A[Amend] General statement of acquisition of beneficial ownership1310/13/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934510/09/2020
424B4Prospectus [Rule 424(b)(4)]32209/25/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934509/24/2020
POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]1109/24/2020
F-1Registration statement for securities of certain foreign private issuers44109/21/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934609/21/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934509/21/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934609/17/2020
SC 13DGeneral statement of acquisition of beneficial ownership1109/14/2020
DRSDraft Registration Statement38809/11/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934609/10/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934509/08/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19345008/18/2020
<<
First
<
Prev
1234